Authors: van den Brink, EN Turenhout, EAM Bovenschen, N Heijnen, BGADH Mertens, K Peters, M Voorberg, J

Citation: En. Van Den Brink et al., Multiple VH genes are used to assemble human antibodies directed toward the A3-Cl domains of factor VIII, BLOOD, 97(4), 2001, pp. 966-972

Authors: Voorberg, J van den Brink, EN

Citation: J. Voorberg et En. Van Den Brink, Phage display technology: A tool to explore the diversity of inhibitors toblood coagulation factor VIII, SEM THROMB, 26(2), 2000, pp. 143-150

Authors: van den Brink, EN Turenhout, EAM Bank, CMC Fijnvandraat, K Peters, M Voorberg, J

Citation: En. Van Den Brink et al., Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain, BLOOD, 96(2), 2000, pp. 540-545

Authors: van den Brink, EN Turenhout, EAM Davies, J Bovenschen, N Fijnvandraat, K Ouwehand, WH Peters, M Voorberg, J

Citation: En. Van Den Brink et al., Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes, BLOOD, 95(2), 2000, pp. 558-563

Authors: Boorsma, DM Flier, J van den Brink, EN Sampat, S Walg, HL Willemze, R Tensen, CP Stoof, TJ

Citation: Dm. Boorsma et al., IP-10 mRNA expression in cultured keratinocytes is suppressed by inhibition of protein kinase-C and tyrosine kinase and elevation of cAMP, CYTOKINE, 11(7), 1999, pp. 469-475

Authors: van den Brink, EN Timmermans, SMH Turenhout, EAM Bank, CMC Fijnvandraat, K Voorberg, J Peters, M

Citation: En. Van Den Brink et al., Longitudinal analysis of factor VIII inhibitors in a previously untreated mild haemophilia A patient with an Arg(593)-> Cys substitution, THROMB HAEM, 81(5), 1999, pp. 723-726